These results indicated that the mRNA expression of E2F1/2/3/4/5/7/8 was significantly related to the prognosis of ccRCC patients, and they may be used as biomarkers to predict survival in patients with ccRCC. This evidence concerns the gene E2F1 and nonpapillary renal cell carcinoma.